Bayer, Meda sue Apotex over nasal spray

Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro (azelastine) patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Apotex asks Supreme Court to overturn Teva ‘Bendeka’ ruling

21 December 2021 Apotex has asked the US Supreme Court to reconsider a US Court of Appeals for the Federal Circuit ruling upholding four of Teva Pharmaceutical’s cancer drug patents.

Americas

Merck Sharp & Dohme fails to secure new nasal spray trial

12 February 2018 The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9.

Americas

Endo sues Lupin over nasal spray

2 August 2017 Drugs maker Endo Pharmaceuticals has accused Lupin Atlantis, a subsidiary of Lupin, of patent infringement.